The in vitro activity of rosamicin was determined against 231 strains of anaerobic bacteria and compared with the activity of erythromycin against the same strains. Rosamicin and erythromycin had similar activity against strains ofPeptostreptococcus and gram-positive nonsporeforming bacilli. Rosamicin was somewhat more active against strains of Peptococcus, Clostridium, and gramnegative anaerobes. All strains ofBacteroides fragilis tested were inhibited by 4 Mg of rosamicin or less per ml, whereas only 76% of them were inhibited by this concentration of erythromycin. Rosamicin was distinctly more active against Fusobacterium nucleatum. Because of its in vitro activity, further investigation of the pharmacology of this drug is warranted.
Rosamicin, a macrolide antibiotic produced by Micromonospora rosaria (3), is chemically similar to erythromycin. It is reported to have activity equal or superior to erythromycin against gram-positive bacteria and improved activity against gram-negative bacteria (3, 4) . Previous studies comparing in vitro activity of rosamicin and erythromycin have been done with aerobic and facultative bacteria (1) . The purpose of the present study was to determine the activity of rosamicin against a variety of anaerobic bacteria and compare this with the activity of erythromycin against these same bacteria.
A total of 231 strains of anaerobic bacteria was tested. Most of these had been isolated from clinical material obtained between September 1972 and December 1974. Nine of the strains of Bacteroides melaninogenicus were type or reference strains and seven of them were oral or fecal strains from healthy individuals. All organisms were isolated and identified as outlined in the Wadsworth Anaerobic Bacteriology Manual (2).
Rosamicin was supplied by Schering Corp., Bloomfield, N.J., and erythromycin estolate was supplied by Eli Lilly and Co., Indianapolis, Ind. Stock solutions containing 1,280 ug/ml were made by first dissolving each antibiotic in 95% ethyl alcohol and then adding water to obtain a final concentration of 9.5% alcohol. Further dilutions of each antibiotic were made in water.
Agar dilution susceptibility tests were performed as previously described (2) .
The activity of rosamicin and erythromycin against gram-positive anaerobic bacteria is shown in Table 1 . With the Peptostreptococcus species and gram-positive nonsporeforming bacilli, the activity of the two antibiotics was essentially the same. With the majority of Peptococcus species, Clostridium perfringens and most other strains of Clostridium species, rosamicin was approximately fourfold more active than erythromycin. Organisms which were resistant to 8 ug of rosamicin or more per ml were two strains of Peptococcus variabilis, one strain each of P. magnus and P. prevotii, and two strains of Clostridium innocuum. These same strains were resistant to 128 gg of erythromycin or more per ml. Additionally, one strain ofP. prevotii had a minimal inhibitory concentration of 4 ,ug of rosamicin per ml but was resistant to 128 ,ug of erythromycin or more per ml.
The activity of the two antibiotics against gram-negative anaerobes is shown in Table 2 . Rosamicin was distinctly more active than erythromycin against Fusobacterium nucleatum, with all strains being inhibited by 0.5 ,ug or less per ml. It was somewhat more active than erythromycin against other gramnegative anaerobes. All strains of Bacteroides fragilis were inhibited by 4 ug or less per ml, whereas only 76% of them were inhibited by 4 ,ug of erythromycin or less per ml. One Bacteroides species required 8 ug of rosamicin per ml for inhibition and two strains of Fusobacterium species required 8 Mg or more of rosamicin per ml for inhibition. These same 
